SCHEMBL1230282

SCHEMBL1230282

O=c1c2cc(O)ccc2oc2cccc(O)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.71
MGAM O43451 3/20 0.71
FASN P49327 1/20 0.71
EGFR P00533 1/20 0.58
GAA P10253 1/20 0.58
SI P14410 1/20 0.58
MGAM2 Q2M2H8 1/20 0.58
ESR1 P03372 3/20 0.56
ESR2 Q92731 3/20 0.56
DHFR P00374 1/20 0.54
CYP1A2 P05177 1/20 0.54
KCNH2 Q12809 1/20 0.54
ATP1A1 P05023 1/20 0.51
ATP1B1 P05026 1/20 0.51
ATP1A3 P13637 1/20 0.51
ATP1B2 P14415 1/20 0.51
ATP1A2 P50993 1/20 0.51
ATP1B3 P54709 1/20 0.51
FXYD2 P54710 1/20 0.51
ATP1A4 Q13733 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30786764 1.00 MAOA (0.71) MAOAMGAMFASNEGFRGAA
SCHEMBL30711777 1.00 MAOA (0.71) MAOAMGAMFASNEGFRGAA
Xanthone SCHEMBL27993220 0.94 MAOA (0.79) MAOAMGAMFASNEGFRGAA
SCHEMBL2316559 0.87 MAOA (0.70) MAOAMGAMFASNEGFRGAA
SCHEMBL16527412 0.84 MAOA (0.66) MAOAMGAMFASNEGFRGAA
SCHEMBL2315926 0.83 MGAM (1.00) MAOAMGAMFASNGAASI
SCHEMBL31573813 0.83 MAOA (0.69) MAOAMGAMFASNEGFRGAA
SCHEMBL28057934 0.83 MAOA (0.69) MAOAMGAMFASNEGFRGAA
SCHEMBL30346453 0.82 MAOA (1.00) MAOAMGAMEGFRGAASI
SCHEMBL30600021 0.82 MAOA (1.00) MAOAMGAMEGFRGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240315965-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2024-09-26 US claimed
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 US claimed
WO-2022182523-A1 COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2022-09-01 WO claimed
WO-2022182527-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2022-09-01 WO claimed
WO-2021158575-A1 COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2021-08-12 WO claimed
WO-2021158573-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2021-08-12 WO claimed
EP-0496349-B1 Coating solution for preventing adhesion of polymer scale and method for its use SHINETSU CHEMICAL CO (JP) 1996-04-10 EP claimed
EP-0496349-A1 Coating solution for preventing adhesion of polymer scale and method for its use SHIN-ETSU CHEMICAL CO., LTD. (JP) 1992-07-29 EP claimed
JP-4154804-A None JP disclosed
EP-2841109-B1 PRODRUGS OF HYDROXYL-COMPRISING DRUGS ASCENDIS PHARMA AS (DK) 2026-04-15 EP disclosed
US-20250161394-A1 Compositions Comprising Kavalactones NATURAL EXTRACTION SYS LLC (US) 2025-05-22 US disclosed
EP-3782649-B1 BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS ASCENDIS PHARMA AS (DK) 2025-05-14 EP disclosed
WO-2025072721-A1 COMPOSITIONS UVAGELESS LLC (US) 2025-04-03 WO disclosed
US-20240315965-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2024-09-26 US disclosed
EP-0496349-B1 Coating solution for preventing adhesion of polymer scale and method for its use SHINETSU CHEMICAL CO (JP) 1996-04-10 EP disclosed
US-5241022-A Polyvinyl alcohol with saponification of not less than seventy percent and quinone SHIN-ETSU CHEMICAL CO., LTD. (JP) 1993-08-31 US disclosed
EP-0496349-A1 Coating solution for preventing adhesion of polymer scale and method for its use SHIN-ETSU CHEMICAL CO., LTD. (JP) 1992-07-29 EP disclosed
JP-H04154804-A AGENT FOR PREVENTING DEPOSITION OF SCALE IN PRODUCTION OF VINYL CHLORIDE POLYMER AND PREVENTION PROCESS SHIN ETSU CHEM CO LTD 1992-05-27 JP disclosed
EP-0148787-A2 Positive type photosensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1985-07-17 EP disclosed
US-3931026-A ELECTRICALLY INSULATING ENCAPSULATING COMPOSITION FOR SEMICONDUCTOR DEVICES SEMIKRON GESELLSCHAFT FUR GLEICHRICHTERBAU UND ELEKTRONIK M.B.H. (DT) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES FABP2, FABP4, GUSB MAOA 3718/4885MGAM 2363/4885FASN 1020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.